Gastrointestinal Flashcards

(384 cards)

1
Q

Define achalasia

A

a oesophageal motility disorder, characterised by loss of peristalsis and failure of the lower oesophageal sphincter (LOS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Explain the aetiology / risk factors of achalasia

A

Degeneration of ganglion cells of the myenteric plexus in the oesophagus due to an unknown cause.

Oesophageal infection with Trypanosoma cruzi seen in Central and South America produces a similar disorder (Chagas’ disease).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Summarise the epidemiology of achalasia

A

Annual incidence: 1 in 100000.

Usual presentation age: 25–60 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Recognise the presenting symptoms of achalasia

A

Insidious onset and gradual progression of:

  • intermittent dysphagia involving solids and liquids;
  • difficulty belching;
  • regurgitation (particularly at night);
  • heartburn;
  • chest pain (atypical/cramping, retrosternal);
  • weight loss.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Recognise the signs of achalasia on physical examination

A

Signs of complications (e.g. cachectic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Identify appropriate investigations for achalasia and interpret the results

A

1st Line:

  • Barium swallow: Dilated oesophagus which smoothly tapers down to the sphincter (beak- shaped).
  • Endoscopy: To exclude malignancy which can mimic achalasia.
  • Manometry:
  • -> Elevated resting LOS pressure (>45 mmHg);
  • -> incomplete LOS relaxation;
  • -> absence of peristalsis in the distal (smooth muscle portion) of the oesophagus.

Other Ix:

  • CXR: widened mediastinum, double right heart border (dilated oesophagus), an air-fluid level in the upper chest and absence of gastric bubble.
  • serology: for antibodies against T. cruzi
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define acute cholangitis

A

Infection of the bile duct; usually bacterial of duodenal source

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Explain the aetiology / risk factors of acute cholangitis

A

Bile duct obstruction: usually caused by gall stones
- Can be benign structuring (tumour) or malignancy (pancreatic, gall bladder, bile duct)
- Iatrogenic: post-operative damage/altered structure of bile duct
Pathogenesis: increased pressure in bile duct brings bacteria in contact with blood, resulting in infection Risk Factors: age, female, cirrhosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Summarise the epidemiology of acute cholangitis

A

15% have gallstones; 2-3% will develop acute cholangitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Recognise the presenting symptoms of acute cholangitis

A

RUQ abdominal pain; fever, rigors, malaise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Recognise the signs of acute cholangitis on physical examination

A

Jaundice, RUQ tenderness
Charcot’s Triad: Abdominal pain, jaundice and fever (15-20% of cases)
Worsened condition => Reynold’s pentad (add septic shock and mental confusion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Identify appropriate investigations for acute cholangitis and interpret the results

A

Bloods: FBC (raised WCC), CRP (raised); LFTs (obstructive picture: raised bilirubin, ALP), cultures
USS: distinguish between cholangitis and cholecystitis
MRCP: better imaging than USS
ERCP: gold standard test for biliary obstruction (but it is invasive)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Generate a management plan for acute cholangitis

A

Fluids, antiobiotics (ciprofloxacin, metronidazole), vasopressors

Unblock the bile duct: 24-48hrs after admission, once settled

  • ERCP (dilation of duct/removal of stones)
  • Lithotripsy: acoustic shock waves to break stones
  • Cholecystectomy: removal of gall bladder
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Identify the possible complications of acute cholangitis and its management

A

Recurrent biliary pain; jaundice; further episodes; death risk increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Summarise the prognosis for patients with acute cholangitis

A

Risk of death (multiple organ failure); 10-30% mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Define alcoholic hepatitis

A

Inflammatory liver injury caused by chronic heavy alcohol abuse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Explain the aetiology / risk factors of alcoholic hepatitis

A

One of three alcoholic liver diseases (hepatitis; steatosis; cirrhosis)
Histopathology: centrilobular ballooning, DEGENERATION AND NECROSIS OF HEPATOCYTES; STEATOSIS, neutrophilic inflammation, cholestasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Summarise the epidemiology of alcoholic hepatitis

A

10-35% of heavy drinkers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Recognise the presenting symptoms of alcoholic hepatitis

A

May remain asymptomatic and undetected; mild illness with nausea, malaise, epigastric or right hypochondrial pain
More severe: jaundice, abdominal discomfort/swelling, swollen ankles, GI bleed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Recognise the signs of alcoholic hepatitis on physical examination

A

Excess Alcohol: malnourished, palmar erythema, Dupuytren’s contracture, facial telangiectasia, parotid enlargement, spider naevia, gynaecomastia, hepatomegaly
Alcoholic Hepatitis: febrile, tachycardic, jaundiced, bruising, encephalopathy (e.g. liver flap), ascites, hepatomegaly, splenomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Identify appropriate investigations for alcoholic hepatitis and interpret the results

A

BLOODS: FBC (reduced Hb, platelets; increased MCV and WCC), LFT (increased transaminases, bilirubin, GGT, ALP, reduced albumin) U&Es ( urea and K+ low), Clotting (prolonged PT)
USS: for other causes
Upper GI endoscopy: investigate varices
Liver biopsy: distinguish other causes of hepatitis Electroencephalogram: indicative for encephalopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Generate a management plan for alcoholic hepatitis

A

ACUTE:
- Thiamine, VitC, monitor electrolytes and glucose
- Treat encephalopathy (lactulose)
- Ascites: diuretics (spironolactone and furosemide)
NUTRITION:
- Oral/NG feeding
- Avoid protein restriction unless encephalopathic
Steroid Therapy: Reduce short-term mortality
Long Term: see alcohol dependence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Identify the possible complications of alcoholic hepatitis and its management

A

Acute liver decompensation; hepatorenal syndrome; cirrhosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Summarise the prognosis for patients with alcoholic hepatitis

A

10% mortality in 30 days, 40% in 1 year; most progress to cirrhosis with continued alcohol intake Maddrey’s discriminant factor: (bilirubin/17) + (PT prolongation x 4.6) [>32 = > 50% 30 day mortality) Glasgow Alcoholic Gepatitis score (GAHS) if >9, >50% 30 day mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Define anal fissure
A break or tear in the skin of the anal canal (usually posterior midline)
26
Explain the aetiology / risk factors of anal fissure
Stretching of the anal mucosa beyond capability. HARD STOOLS, PREGNANCY, OPIATE ANALGESIA - Constipation - Passing large, hard stools - Prolonged diarrhoea - Childbirth trauma; sexual activity; Crohn’s Disease; Ulcerative Colitis - Spasming of Internal Anal Sphincter: impaired blood supply to fissure, causing impaired healing - STIs can cause breakdown of skin (syphilis, herpes)
27
Summarise the epidemiology of anal fissure
1:350; occur in 15-40 yrs, more common in men
28
Recognise the presenting symptoms of anal fissure
A tear or paper cut-like scar in the skin of the anal canal Pain on defecation
29
Recognise the signs of anal fissure on physical examination
Appearance of scar in midline, extending from the anal opening
30
Identify appropriate investigations for anal fissure and interpret the results
Investigate possible causes of fissure (proctoscopy, sigmoidoscopy or colonoscopy for CD or colorectal cancer) DO NOT attempt DRE as it is painful
31
Generate a management plan for anal fissure
Non-surgical: - gt ointment and lidocaine ointment, with diltiazem (calcium channel blocker) - Topical anaesthetics, high-fiber diets and stool softeners - 2nd line: botulinum toxin injection and topical diltiazem Surgical: for those who have unsuccessfully tried non-surgical treatment for 1-3 months - Lateral Sphincterectomy
32
Identify the possible complications of anal fissure and its management
Complications of treatment include Incontinence
33
Summarise the prognosis for patients with anal fissure
Most can be non-surgically treated
34
Define appendicectomy
Surgical removal of the vermiform appendix
35
Summarise the indications for an appendicectomy
acute appendicitis
36
Identify the possible complications of an appendicectomy
Wound infection, abscess, ileus
37
Contraindications of appendicectomy
``` Haemodynamic instability Lack of surgical expertise Severe abdominal distension Generalised peritonitis Severe pulmonary disease Pregnancy ```
38
Define amyloidosis
Extracellular deposition of amyloid fibrils; three types: - AL (light chain) - AA (serum A amyloid) - ATTR (familial)
39
Explain the aetiology / risk factors of amyloidosis
Amyloid fibril deposition disrupts the structure and function of normal tissue; amyloidosis is classified according to fibril subunit: - AL – monoclonal immunoglobulin light chains; associated with plasma cell disorders i.e. multiple myeloma - AA – Serum amyloid protein A; associated with chronic inflammatory conditions (IBD and rheumatoid arthritis) - ATTR – a genetic variant; autosomal dominant transmitted mutations
40
Summarise the epidemiology of amyloidosis
Primary - AL Amyloidosis: 3-600 annual cases Secondary - AA Amyloidosis: 1-5% of those with chronic inflammatory conditions Hereditary Amyloidosis: 5% of patients with systemic amyloidosis
41
Recognise the presenting symptoms of amyloidosis
Multi-systemic affects: - Renal: renal failure, oedema - Vascular: Periorbital Purpura - PNS: pain/numbness in arms and legs - GI: macroglossia, bleeding, weight loss, malabsorption - Cardiac: angina, orthopnoea, PND - Haematological: bleeding diathesis - Neurological: carpal tunnel syndrome - Dermatological: waxy skin, easy bruising - Joints: painful joints
42
Recognise the signs of amyloidosis on physical examination
Multi-systemic Affects: - Renal: proteinuria - Cardiac: arrhythmias, heart failure - GI: hepatosplenomegaly - Neurological: sensory and motor neuropathy - Skin: purpura around eyes - Joints: tender, swelled joints
43
Identify appropriate investigations for amyloidosis and interpret the results
Tissue biopsy: congo red stain; to diagnose AA; poor diagnostic power for AL Urine: proteinuria, free immunoglobulin light chains for AL Blood: CRP, ESR, rheumatoid factor, LFTs, U&Es
44
Define appendicitis
Inflammation of the appendix
45
Explain the aetiology / risk factors of appendicitis
Organisms of the gut invade the appendix
46
Summarise the epidemiology of appendicitis
very common
47
Recognise the presenting symptoms of appendicitis
pain in the umbilical region that migrates to the right iliac fossa region Diarrhoea/constipation Anorexia and vomiting (rare)
48
Recognise the signs of appendicitis on physical examination
Rovsing's sign: pushing down on the LIF causes an increase in pain in the RIF Psoas sign: pain on extending the hip Cope sign: pain on flexion and internal rotation of the right hip Rebound tenderness: when infection involves the peritoneum
49
Identify appropriate investigations for appendicitis and interpret the results
FBC: CRP, neutrophil leucocytosis CT: high diagnostic accuracy (reduces –ve appendicectomy, but can cause delay) USS: appendix not always visualised
50
Generate a management plan for appendicitis
Prompt appendicectomy | Antibiotics: metronidazole and cefuroxime
51
Identify the possible complications of appendicitis and its management
Perforation: more common if feacolith is present; young children Appendix Mass: when inflamed appendix becomes covered in omentum (US/CT helps with diagnosis) Appendix Abscess: can result in appendix mass also
52
Summarise the prognosis for patients with appendicitis
Most recover easily after surgery, between 10-28 day recovery
53
Define autoimmune hepatitis
Chronic hepatitis of unknown aetiology; characterised by autoimmune features, hyperglobulinaemia and the presence of circulating antibodies
54
Explain the aetiology / risk factors of autoimmune hepatitis
Genetically predisposed individual – environmental agent leads to hepatocyte expression of HLA antigens, which become focus of t-cell mediated attack Type 1 (classic): ANA, anti-smooth muscle antibodies (ASMA), anti-actin antibodies (AAA), anti-soluble liver antigen (anti-SLA) Type 2: antibodies to liver/kidney microsomes
55
Summarise the epidemiology of autoimmune hepatitis
Type 1: all age groups (mainly young women) | Type 2: generally disease of girls and young women
56
Recognise the presenting symptoms of autoimmune hepatitis
``` May be asymptomatic and discovered incidentally by deranged LFTs Insidious Onset: malaise, fatigue, anorexia, weight loss, nausea, jaundice, amenorrhoea, epistaxis Acute Hepatitis (25%): RUQ pain, fever, anorexia, jaundice, nausea, vomiting, diarrhoea Family history of autoimmune disease (e.g. T1DM, vitilgo) ```
57
Recognise the signs of autoimmune hepatitis on physical examination
Chronic Liver Disease Signs: spider naevi, gynacomastea, abnormal hair growth Late Features: Ascites; oedema and encephalopathy Cushingoid Features: round face, cutaneous striae, acne, hirsuitism
58
Identify appropriate investigations for autoimmune hepatitis and interpret the results
Bloods: LFTs (increase AST, GGT, ALT, AlkPhos, bilirubin) Clotting (increase PT) FBC (mild reduced Hb and platelets and WCC- hypersplenism in portal hypertension) Liver Biopsy: needed for diagnosis; interface hepatitis or cirrhosis Other: to rule out other causes e.g. viral serology, ferritin/trasnferritin USS/CT/MRI: of liver and abdomen: visualise lesions ERCP: rule out Primary Sclerosing Cholangitis
59
Define Barrett’s oesophagus
a change in the normal squamous epithelium of the oesophagus to specialised intestinal metaplasia. [Metaplasia of the squamous epithelium of the lower third of the oesophagus to columnar epithelium] Mucosal inflammation and erosion, and replacement of mucosa with metaplastic columnar epithelium, in the lower third of the oesophagus. Presence of goblet cells is necessary for diagnosis
60
Explain the aetiology / risk factors of Barrett’s oesophagus
Chronic inflammation: principal cause is GORD | RF: acid or bile reflux/GORD, male sex, age, white, family history of BO or oesophageal adenocarcinoma, obesity, smoking
61
Summarise the epidemiology of Barrett’s oesophagus
Men are 8x more at risk | Caucasian is at a higher risk
62
Recognise the presenting symptoms of Barrett’s oesophagus
Frequent heartburn, dysphagia, haematemesis, retrosternal pain, weight loss
63
Recognise the signs of Barrett’s oesophagus on physical examination
Diagnosis made in imaging
64
Identify appropriate investigations for Barrett’s oesophagus and interpret the results
Upper GI endoscopy with biopsy | barium oesophagram
65
Generate a management plan for Barrett’s oesophagus
If pre-malignant/high-grade dysplasia – oesophageal resection or eradicative mucosectomy If no pre-malignancy or high-grade dysplasia: endoscopic surveillance + biopsy; every 1-3 years - Anti-reflux measures: PPIs (omeprazole)
66
Identify the possible complications of Barrett’s oesophagus and its management
high risk of oesophageal cancer (oesophagogastric junctional adenocarcinoma)
67
Summarise the prognosis for patients with Barrett’s oesophagus
Risk of cancer is 1-7:1000; those with oesophageal cancer have low survival rates (most are <1 year)
68
Define cholecystitis
inflammation of the gallbladder
69
Explain the aetiology / risk factors of cholecystitis
Inflammation of the gallbladder – most commonly by gallstones. But can occur with blockage due to tumour or scarring Risk Factors: age, female, pregnancy, oral contraceptives, obesity, diabetes mellitus Calculous Cholecystitis: gallstones blocking flow; gallbladder can become infected (E. coli, Klebsiella). Can spread to diaphragm Acalculous Cholecystitis: no stones; vasculitis, chemotherapy, major trauma or burns Chronic Cholecystitis: repeated inflammations; may be asymptomatic
70
Summarise the epidemiology of cholecystitis
Accounts for 3-10% of abdominal pain; highest in 50-69 year olds
71
Recognise the presenting symptoms of cholecystitis
RUQ pain, worse on eating fatty foods, nausea and vomiting. Biliary colic preceding cholecystitis
72
Recognise the signs of cholecystitis on physical examination
Fever, tender abdomen, palpable gallbladder, jaundice | Murphy’s Sign: while pressing on RUQ, pain on inspiration and breath is terminated
73
Identify appropriate investigations for cholecystitis and interpret the results
Bloods: FBC (increased WCC), CRP (elevated), bilirubin (elevated) USS: of RUQ, most commonly used to diagnose CT: if complications (perforation, gangrene) are suspected
74
Generate a management plan for cholecystitis
Surgery: laparoscopic cholecystectomy (early has better prognosis)
75
Identify the possible complications of cholecystitis and its management
Gangrene, gallbladder rupture (abscess, peritonitis), empyema, fistula formation, gallstone ileus
76
Summarise the prognosis for patients with cholecystitis
Pre-complication prognosis is better, 25-30% develop complications
77
Define cirrhosis
End stage of chronic liver damage with replacement of normal liver architecture with diffuse fibrosis and nodules of regenerating hepatocytes.
78
What is decompensated liver failure and what are the symptoms?
Compensated: Np symptoms of the disease Decompensated: cirrhosis has progressed to the point that the liver is having trouble functioning and you start having symptoms of the disease jaundice, ascites, encephalopathy or GI bleeding
79
Explain the aetiology / risk factors of cirrhosis
Most common: chronic alcohol misuse Chronic viral hepatitis: Hep B+C most common worldwide Autoimmune hepatitis Drugs: e.g. methotrexate, hepatotoxic drugs Inherited: α1-Antitrypsin deficiency, haemochromatosis, Wilson’s disease, galactosaemia, CF Vascular: Budd-Chiari syndrome Chronic biliary diseases: primary biliary cirrhosis, PSC, biliary atresia Cryptogenic: 5-10% Non-alcoholic steatohepatitis (NASH): associated with obesity, diabetes, parenteral nutrition, and drugs (amiodarone, tamoxifen) Decompensation: infection, GI bleeding, constipation, alcohol, drugs
80
Summarise the epidemiology of cirrhosis
Top 10 causes of death
81
Recognise the presenting symptoms of cirrhosis
Early and non-specific: anorexia, nausea, fatigue, weakness, weight loss Symptoms (decreased synthetic function): easy bruising, abdominal swelling, ankle oedema Symptoms (reduced detoxification): jaundice, personality changes, altered sleep patterns, amenorrhoea Symptoms (Portal Hypertension): abdominal swelling, haematemesis, PR bleeding or melaena
82
Recognise the signs of cirrhosis on physical examination
Chronic Liver Disease: ABCDE - Asterixes (liver flap) - Bruises - Clubbing - Dupuytren;s Contracture - Erythema - Other: jaundice, gynaecomastia, leukonychia, spider naevia, scratch marks, ascites, hepatomegaly, caput medusa, splenomegaly
83
Identify appropriate investigations for cirrhosis and interpret the results
BLOODS: FBC (lowered Hb, platelets [hypersplenism]) LFTs (can be normal, increased AlkPhos, reduced albumin) Clotting (prolonged PT), Serum AFP Other: to determine cause (serology, α1 antitrypsin, caeruloplasmin {Wilson’s Disease]) Liver Biopsy: percutaneous (trans jugular if ascites or clotting deranged) Imaging: USS, CT, MRI (detect complications, hepatocellular carcinoma, thrombosis), MRCP Endoscopy: examine for varices Child-Pugh Grading: Class A/B/C depending on score
84
Generate a management plan for cirrhosis
Treat cause if possible Advice: avoid alcohol, sedatives, opiates, NSAIDs and drugs that affect the liver, ensure good nutrition Treat complications: - Encephalopathy: treat infections, exclude GI bleed, lactulose - Ascites: diuretics (spironolactone/furosemide), sodium restriction, fluid restriction - Spontaneous Bacterial Peritonitis: antibiotic treatment (cefuroxime and metronidazole) - Surgical: insertion of TIPS (relieve portal hypertension). Liver transplant
85
Identify the possible complications of cirrhosis and its management
Portal hypertension with ascites, encephalopathy or variceal haemorrhage, SBP, hepatocellular carcinoma, peritonitis Renal failure
86
Summarise the prognosis for patients with cirrhosis
Depends on aetiology: generally poor. 5 year survival at 50%, with ascites 2 year survival at 50%
87
Define coeliac disease
Inflammatory disease caused by intolerance to gluten, causing chronic intestinal villous atrophy and malabsorption
88
Explain the aetiology / risk factors of coeliac disease
Sensitivity to the gliadin component of the cereal protein, gluten – triggers an immunological reaction in the small intestine leading to mucosal damage and loss of villi 10% risk of first relatives being affected
89
Summarise the epidemiology of coeliac disease
1:2000; more common in western society
90
Recognise the presenting symptoms of coeliac disease
pain, tiredness,
91
Recognise the signs of coeliac disease on physical examination
Anaemia: pallor Malnutrition: short stature, abdominal distension, wasted buttocks in children Vitamin/Mineral Deficiencies: osteomalcia, easy bruising Intense itchy blisters on elbows/knees/buttocks
92
Identify appropriate investigations for coeliac disease and interpret the results
Bloods: FBC, iron, folate, U&Es, albumin, Ca2+ and phosphate Serology: testing for IgG anti-glandin, tissue transglutaminase (tTG) Stool: culture to exclude infection D-xylose test: reduced urinary excretion after oral xylose (small bowel malabsorption) Endoscopy: direct visualisation shows villous atrophy in small intestine (jejenum and ileum), giving smooth, flat appearance to mucosa. Biopsy: villous atrophy with crypt hyperplasia of duodenum
93
Generate a management plan for coeliac disease
Advice: Withdrawal of gluten from the diet and educating on dietary advice Medical: vitamin and mineral supplements
94
Identify the possible complications of coeliac disease and its management
Iron, folate and vitamin B12 deficiencies; osteomalacia; ulcerative jejunoileitis; bacterial overgrowth
95
Summarise the prognosis for patients with coeliac disease
With strict adherence, most patients make a full recovery; symptoms resolving in weeks Life-long diet changes need to be made
96
Define Crohn's disease
Chronic granulomatous inflammatory disease that can affect any part of the GI tract. Most commonly in ileum and colon
97
Explain the aetiology / risk factors of Crohn's disease
Combination of environmental factors and genetic predisposition Genetics: siblings are 30x more likely to develop it; Immune system: impaired innate immunity Environmental Factors: smoking, oral contraceptives,
98
Summarise the epidemiology of Crohn's disease
5-8:100,000; lower incidence in Asia and east Africa; bimodal onset at 15-30 and 60-80 years
99
Recognise the presenting symptoms of Crohn's disease
Crampy abdominal pain; diarrhoea; fever/malaise/weight loss; symptoms of complications
100
Recognise the signs of Crohn's disease on physical examination
Weight loss; clubbing; anaemia signs Aphthous ulceration of the mouth Perianal skin tags, fistulae and abscesses Signs of complications (eyes, joints or skin)
101
Identify appropriate investigations for Crohn's disease and interpret the results
Blood: FBC, U&Es, LFTs, ESR, CRP (p-anca negative) Stool microscopy and culture: exclude infective colitis AXR: toxic megacolon Erect CXR: to see perforation Small-bowel barium follow-through; reveal fibrosis/strictures, rose thorn appearance Endoscopy (OGD, colonoscopy) and biopsy: differentiate between CD and UC. Will see granulomas in CD.
102
Generate a management plan for Crohn's disease
``` Acute Exacerbation: - Fluid rescus - IV or oral corticosteroids - 5-ASA Analogues (e.g. mesalazine) - Analgesia - Monitor activity markers Long Term: - Steroids: to treat acute exacerbations - 5-ASA analgoues (e.g. mesalazine) to reduce relapses - Immunosuppression: steroid-sparing agents (e.g. azathioprine) to reduce relapse - Anti-TNF agents (e.g. infliximab) to achieve and maintain remission Advice: - Stop smoking - Dietician referral - Education and advice Surgery: - Indicated by failure of medical treatment, failure to thrive in children or complications - Resection of bowel and stoma formation ```
103
Identify the possible complications of Crohn's disease and its management
GI: Haemorrhage, bowel obstruction, perforation, fistulae, GI carcinoma Extra intestinal: uveitis; episcleritis; gallstones; kidney stones
104
Summarise the prognosis for patients with Crohn's disease
Chronic relapsing condition; two thirds will require surgery eventually, and two thirds of these will have >1 procedure.
105
Define diverticular disease
Diverticulosis: presence of diverticulae outpouchings of the colonic mucosa and submucosa throughout the large bowel Diverticular Disease: diverticulosis associated with complications (e.g haemorrhage, infection) Diverticulitis: acute inflammation and infection of the colonic diverticulae Hinchey Classification: - Ia: phlegmon - Ib and II: localised abscesses - III: perforation with purulent peritonitis - IV: faecal peritonitis
106
Explain the aetiology / risk factors of diverticular disease
A low fibre diet can lead to loss of stool bulk, consequently high pressures are required to expel the stool, leading to herniations through the muscularis at weak points Pathogenesis: most common in sigmoid colon; can be obstructed with stool, leading to bacterial overgrowth, injury and diverticulitis
107
Recognise the presenting symptoms of diverticular disease
``` Often asymptomatic (80-90%) Complications: PR bleeding, diverticulitis (LIF pain, fever) diverticular fistulation into the bladder (pneumaturia, faecaluria and recurrent UTIs) ```
108
Recognise the signs of diverticular disease on physical examination
Diverticulitis: tender abdomen, signs of local/generalised peritonitis if perforation occurred
109
Identify appropriate investigations for diverticular disease and interpret the results
Bloods: FBC, clotting, cross-match Barium Enema: demonstrated presence of diverticulae (not in acute; risk of perforation) Flexible sigmoidoscopy and colonoscopy: diverticulae can be seen Acute Setting: CT
110
Generate a management plan for diverticular disease
Asymptomatic: soluble, high-fibre diet. [Anti-inflammatories (mesalazine) under investigation as preventions] GI Bleed: managed conservatively - IV hydration - Bowel rest Surgery: may be necessary with recurrent attacks or complications - Open or laparoscopic approaches - Open Hartmann’s (resection and stoma) - One-Stage resection and anastomosis - Laparoscopic drainage, peritoneal lavage and drain replacement can be effective
111
Identify the possible complications of diverticular disease and its management
Diverticulitis, pericolic abscess, perforation, faecal peritonitis, colonic obstruction, fistula formation, haemorrhage
112
Summarise the prognosis for patients with diverticular disease
10-25% will have >1 episode of diverticulitis
113
Define gallstones and biliary colic
presence of solid concretions in the gallbladder. Gallstones form in the gallbladder but may exit into the bile ducts. Symptoms ensue if a stone obstructs the cystic, bile, or pancreatic duct. Biliary colic is right upper quadrant pain, radiating to shoulder
114
Explain the aetiology / risk factors of gallstones and biliary colic
gallstones: 90% are made of cholesterol. form in the gall bladder, but can move into the ducts, where they can cause symptoms BC: Obstruction of common bile duct/cystic duct by a gall stone. Acute pain can be exacerbated by certain foods (high in fat) Risk Factors: age, female, family history, increased oestrogen exposure (pregnancy, birth control) diabetes mellitus, obesity, rapid weight loss, FHx
115
Summarise the epidemiology of gallstones and biliary colic
high prevalence, usually symptomatic 2-3% risk of developing biliary colic
116
Recognise the presenting symptoms of gallstones and biliary colic
Gallstones are highly prevalent, but most (80%) are asymptomatic. Pain: sharp RUQ pain, radiating to right shoulder/back, can follow high fat meals, lasts 30-120 minutes, nausea, vomiting, Other presentations Biliary colic: is characterised by steady, severe pain (intensity >5 on a scale of 1-10) in the right upper quadrant (RUQ) of the abdomen lasting more than 15-30 minutes. An attack of simple biliary colic commonly requires an analgesic but should resolve within 5 hours. Cholecystitis: biliary pain lasting more than 5 hours is accompanied by features of inflammation: fever, marked RUQ tenderness (Murphy's sign), and leukocytosis. Some patients progress to sepsis. Occasionally, stones can perforate the gallbladder, leading to intestinal obstruction (gallstone ileus). Choledocholithiasis: when stones obstruct the bile ducts, biliary-type pain is accompanied by cholestasis, which manifests as jaundice. More sinister is acute cholangitis, characterised by Charcot's triad of biliary pain, jaundice, and fever. Acute cholangitis represents a medical emergency. Acute pancreatitis: epigastric pain radiating to the back results from bile duct stones obstructing the pancreatic ducts. Inflammatory features include peritonitis.
117
Recognise the signs of gallstones and biliary colic on physical examination
Biliary colic: Right upper quadrant or epigastric tenderness. Acute cholecystitis: Tachycardia, pyrexia, right upper quadrant or epigastric tenderness. There may be guarding +/- rebound. Murphy's sign is elicited by placing a hand at the costal margin in the RUQ and asking the patient to breathe deeply. Patient stops breathing as the inflamed gallbladder descends and contacts the palpating fingers. Ascending cholangitis: Pyrexia, right upper quadrant pain, jaundice.
118
Identify appropriate investigations for gallstones and biliary colic and interpret the results
Bloods: usually normal, LFTs can show raised bilirubin and AlkPhos FBC, LFTs, serum lipase and amylase, abdominal ultrasound MRCP, endoscopic ultrasound scan, ECRP, abdominal CT scan
119
Generate a management plan for gallstones and biliary colic
No treatment for asymptomatic cholecystolithiasis symptomatic cholecystolithiasis: Laparoscopic cholecystectomy cholelithiasis: ERCP, lithotripsy, papillary balloon dilation, stent Relief of symptoms and electrolyte/fluid imbalance - Anti-emetics (dimenhydrinate) - Pain: NSAIDs (diclofenac)
120
Identify the possible complications of gallstones and biliary colic and its management
Cholecystitis, cholangitis, pancreatitis Delayed surgery can cause pancreatitis, empyema/perforation of gallbladder, cholecystitis, cholangitis, obstructive jaundice
121
Summarise the prognosis for patients with gallstones and biliary colic
Good, dependant on development of complications The outlook for patients with symptomatic cholelithiasis managed by cholecystectomy is favourable. The same holds for patients with choledocholithiasis who undergo ERCP with biliary sphincterotomy and stone extraction, followed later by cholecystectomy.
122
Define gastric cancer
Gastric malignancy, most commonly adenocarcinoma, more rarely lymphoma, leiomyosarcoma. cancer deriving from the stomach
123
Explain the aetiology / risk factors of gastric cancer
50% involve pylorus 25% lesser curve 10% cardia 2-7% are lymphomas Most cases are probably caused by environmental insults in genetically predisposed individuals that lead to mutation and subsequent unregulated cell growth. Risk Factors: being >55, male, poor socio-economic status, • H.pylori infection; • atrophic gastritis; • diet high in smoked, processed foods and nitrosamines; low vegetable consumption • smoking • alcohol
124
Summarise the epidemiology of gastric cancer
Common cause of cancer death worldwide, highest incidence in Asia (Japan). Sixth most common cancer in UK (annual incidence is 15 in 100000) Age>50 years. Cancer of the antrum/body is becoming less common, while that of the cardia and gastro- oesophageal junction is increasing.
125
Recognise the presenting symptoms of gastric cancer
In early phases, it is often asymptomatic. Early satiety or epigastric discomfort. Weight loss, anorexia, nausea and vomiting. dyspepsia Haematemesis, melaena, symptoms of anaemia. Dysphagia (tumours of the cardia). Symptoms of metastases, particularly abdominal swelling (ascites) or jaundice (liver involvement).
126
Recognise the signs of gastric cancer on physical examination
Physical examination may be normal. Epigastric mass. Abdominal tenderness. Ascites. Hepatomegaly, jaundice, ascites acanthosis nigricans Signs of anaemia. Many eponymous signs: Virchow’s node/Troisier’s sign: Lymphadenopathy in left supraclavicular fossa. Sister Mary Joseph node: Metastatic nodule on umbilicus. Krukenberg’s tumour: Ovarian metastases.
127
Identify appropriate investigations for gastric cancer and interpret the results
Upper GI endoscopy: With multiquadrant biopsy of all gastric ulcers. Blood: FBC (for anaemia), LFT. CEA, Ca19-9, Ca72-4 CT/MRI: Staging of tumour and planning of surgery. Ultrasound of liver: Staging of tumour. Bone scan: Staging of tumour. Endoscopic ultrasound: Assesses depth of invasion and lymph node spread. Laparoscopy: May be needed to determine if tumour is resectable.
128
Define gastro-oesophageal reflux disease
Inflammation of the oesophagus caused by reflux of gastric acid and/or bile
129
Explain the aetiology / risk factors of gastro-oesophageal reflux disease
Disruptions of mechanisms that prevent reflux (physiological etc.) Risk Factors: obesity, pregnancy (increase in abdominal pressure), smoking, diet, hiatus hernia, increase in age, FHx
130
Summarise the epidemiology of gastro-oesophageal reflux disease
Common, 5-10% of adults
131
Recognise the presenting symptoms of gastro-oesophageal reflux disease
Substernal burning discomfort or ‘heartburn’, aggravated by supine position, bending, large meals and drinking alcohol acid regurgitation Waterbrash Aspiration results in voice hoarseness, laryngitis, nocturnal cough and wheeze dysphagia, bloating, early satiety
132
Recognise the signs of gastro-oesophageal reflux disease on physical examination
Usually normal. | Occasionally, epigastric tenderness, wheeze on chest auscultation, dysphonia.
133
Identify appropriate investigations for gastro-oesophageal reflux disease and interpret the results
Upper GI Endoscopy, biopsy: confirm presence of oesophagitis, exclude malignancy Barium Swallow: detect hiatus hernia, peptic stricture CXR: incidental hiatus hernia findings 24 hour oesophageal pH monitoring: determines temporal relationship to symptoms
134
Generate a management plan for gastro-oesophageal reflux disease
Advice: - Lifestyle changes, weight loss, elevating head - Avoid provoking factors, stopping smoking, lower fat meals Medical: - Antacids - PPIs (e.g. lansoprazole) - H2 antagonists (e.g. ranitidine) Endoscopy: - Annual endoscopic surveillance for Barrett’s Oesophagus Surgery: - Anti-reflux surgery
135
Identify the possible complications of gastro-oesophageal reflux disease and its management
Oesophageal ulceration; peptic stricture; anaemia; Barrett’s; oesophageal adenocarcinoma
136
Summarise the prognosis for patients with gastro-oesophageal reflux disease
50% respond to lifestyle changes alone
137
Define gastroenteritis
Acute inflammation of the lining of the GI tract, manifested by nausea, vomiting, diarrhoea and abdominal discomfort
138
Explain the aetiology / risk factors of gastroenteritis & infectious colitis i.e. name some of the pathogens
``` Viral: - Rotavirus, astrovirus, calcivirus Bacterial: - Campylobacter jejuni, Escherichia coli, Salmonella, Shigella Protozoal: - Entamoeba histolytica Toxins: - From Staphylococcus aureus, Clostridium botulinum ``` Commonly contaminated foods: improperly cooked meats, old rice, eggs, poultry CHESS organisms - Campylobacter - Haemorrhagic E. Coli - Entamoeba histolytica - Shigella - Salmonella
139
Summarise the epidemiology of gastroenteritis
Common, often under-reported
140
Recognise the presenting symptoms of gastroenteritis
Sudden onset nausea, vomiting, anorexia Diarrhoea, abdominal pain/discomfort, fever, malaise Enquire: recent travel, antibiotic use and recent food intake Time: toxins (1-24 hours), bacterial (12 hours)
141
Recognise the signs of gastroenteritis (&IC)
Diffuse abdominal tenderness, abdominal distension and bowel sounds are increased Severe: pyrexia, dehydration, hypotension, peripheral shutdown
142
Identify appropriate investigations for gastroenteritis & infectious colitis and interpret the results
Bloods: FBC, culture, U&Es Stool: faecal microscopy AXR/USS: exclude other causes Sigmoidoscopy: only if IBD needs to be excluded INFECTIOUS COLITIS Bloods: FBC, CRP, ESR Stool: MC&S
143
Generate a management plan for gastroenteritis & infectious colitis
Bed rest, fluids and electrolyte replacement (advise increase oral fluid intake to compensate for the water lost from diarrhoea and vomiting) IV rehydration may be required in severe cases. Don;'t conventionally give antibiotics unless a bacteria has been isolated. Botulism: botulinum antitoxin IM, manage in ITU
144
Identify the possible complications of gastroenteritis & infectious colitis and its management
Dehydration, electrolyte imbalance, prerenal failure, sepsis, shock Botulinum: respiratory muscle paralysis
145
Summarise the prognosis for patients with gastroenteritis & infectious colitis
Generally good, majority are self-limiting
146
Define infectious colitis
An inflammation of the large bowel, with an infective cause
147
Summarise the epidemiology of infectious colitis
Rare, in those with lower hygiene levels, and contaminated food
148
Recognise the presenting symptoms of infectious colitis
Bloody diarrhoea, generalised abdominal pain, vomiting
149
Recognise the signs of infectious colitis on physical examination
Tenderness | DRE: bloody stool
150
Define gastrointestinal perforation
A hole in the wall of the gastrointestinal tract
151
Explain the aetiology / risk factors of gastrointestinal perforation
Gastric ulcers, duodenal ulcers, appendicitis, gastrointestinal cancer, diverticulitis Iatrogenic: abdominal surgery
152
Summarise the epidemiology of gastrointestinal perforation
10-15% of patients with acute diverticulitis
153
Recognise the presenting symptoms of gastrointestinal perforation
Sudden pain in epigastrium (duodenal ulcer), burning pain in epigastrium (gastric ulcer) Pain starts at perforation site, then spreads Severe abdominal pain, nausea, vomiting and hematemesis
154
Recognise the signs of gastrointestinal perforation on physical examination
Severe abdominal tenderness and rigidity | Fever, silent bowel sounds, distended abdomen, tachycardia, dyspnoea
155
Identify appropriate investigations for gastrointestinal perforation and interpret the results
Bloods: FBC, CRP, ESR, U&Es, LFTs AXR: gas under diaphragm CT Abdomen: may visualise location of perforation
156
Generate a management plan for gastrointestinal perforation
``` Surgical Intervention: peritoneal wash and anatomical repair Conservative: - IV fluids - Antibiotics - Nasogastric aspiration and bowel rest ```
157
Identify the possible complications of gastrointestinal perforation and its management
Peritonitis, bleeding, bowel infarction, sepsis, shock
158
Summarise the prognosis for patients with gastrointestinal perforation
Depends on size and location; worse prognosis in older patients with existing bowel disease
159
Define haemochromatosis
Deficiency of hepcidin, resulting in an accumulation of iron
160
Explain the aetiology / risk factors of haemochromatosis
Defects of the HFE gene
161
Summarise the epidemiology of haemochromatosis
Rare
162
Recognise the presenting symptoms of haemochromatosis
Early: vague and nonspecific (fatigue, weakness) Late: diabetes, bronzing of the skin, impaired memory, depression
163
Recognise the signs of haemochromatosis on physical examination
Hepatomegaly, diabetes mellitus, arrhythmias,
164
Identify appropriate investigations for haemochromatosis and interpret the results
Bloods: serum iron, serum ferritin, transferrin saturation, LFTs Genetic testing: HFE testing Liver biopsy: rarely required
165
Define haemorrhoids
Abnormally enlarged vascular mucosal cushions in the anal canal. They are either internal (above the dentate line) or external (below the dentate line) Internal Haemorrhoids: classified according to the degree of prolapse - First Degree: do not prolapse - Second Degree: prolapse on straining, reduce spontaneously - Third Degree: prolapse on straining, can be reduced manually - Fourth Degree: permanently prolapsed, cannot be reduced They are painless unless strangulated External Haemorrhoids - Can be painful and itchy - May be visible on external examination
166
Explain the aetiology / risk factors of haemorrhoids
Caused by excessive straining due to either chronic constipation or diarrhoea. Repetitive or prolonged straining causes downward stress on the vascular haemorrhoidal cushions, leading to the disruption of the supporting tissue elements with subsequent elongation, dilation, and engorgement of the haemorrhoidal tissues. Other conditions can contribute to the formation of haemorrhoids: an increase in intra-abdominal pressure in pregnancy or ascites. Risk Factors: constipation, prolonged straining, increased abdominal pressure (pregnancy, ascites, childbirth), heavy lifting, chronic cough
167
Summarise the epidemiology of haemorrhoids
13-36% of population
168
Recognise the presenting symptoms of haemorrhoids
May be asymptomatic Bright red, painless rectal bleeding with defecation, not mixed with stool. Anal itching or irritation Feeling of rectal fullness, discomfort or incomplete evacuation Strangulated: intensely painful
169
Recognise the signs of haemorrhoids on physical examination
Non-prolapsed haemorrhoids are not evident on external examination, difficult to feel in DRE Local perianal irritation can be seen in chronic discharge Asking patient to strain can make haemorrhoids visible Thrombosed: purple, swollen, acutely tender, perianal lumps
170
Identify appropriate investigations for haemorrhoids and interpret the results
Bloods: FBC, CRP Proctoscopy: should be carried out to aid diagnosis Flexible sigmoidoscopy/colonoscopy: exclude other pathology
171
Generate a management plan for haemorrhoids
Depends on degree of prolapse Prevention and management of constipation: - Fluids and fibre intake Pain and symptom relief: - Simple analgesia e.g. paracetamol - Topical therapies: topical anaesthetics or corticosteroids Non-Surgical: - Rubber band ligation: band cuts off blood supply, necrotising the haemorrhoid and it falls off - Good for Grade II haemorrhoids Surgical: - Haemorrhoidectomy: painful, performed under GA Thrombosed Haemorrhoids: - Extremely painful, treat conservatively with analgesia
172
Identify the possible complications of haemorrhoids and its management
Skin tags, ischaemia, perianal sepsis, thrombosed haemorrhoids can ulcerate
173
Summarise the prognosis for patients with haemorrhoids
Generally good, 10% may need surgery
174
Define hepatocellular carcinoma
Primary malignancy of hepatocytes, usually occurring in a cirrhotic liver. Mostly occurs in those with chronic liver disease cancer of the hepatocytes
175
Explain the aetiology / risk factors of hepatocellular carcinoma
- Chronic liver damage (e.g. alcoholic liver disease, hepatitis B, hepatitis C, autoimmune disease, primary biliary cirrhosis), - metabolic disease (e.g. haemochromatosis), and - aflatoxins (Aspergillus flavus fungal toxin found on stored grains or biological weapons).
176
Summarise the epidemiology of hepatocellular carcinoma
common makes up 1-2% of malignancies very common malignancy in areas where Hepatitis B and C are endemic, i.e. Asia and sub-Saharan Africa ( 500 in 100,000/year). Not common in the west.
177
Recognise the presenting symptoms of hepatocellular carcinoma
Symptoms of malignancy: Malaise, weight loss, loss of appetite. Symptoms of chronic liver disease: Abdominal distension, jaundice, RUQ pain. Pruritus, bleeding oesophageal varices History of carcinogen exposure: High alcohol intake, Hepatitis B or C, aflatoxins.
178
Recognise the signs of hepatocellular carcinoma on physical examination
Signs of malignancy: Cachexia/weight loss, lymphadenopathy. Hepatomegaly: Nodular (but may be smooth). Deep palpation may elicit tenderness. There may be bruit heard over the liver. Signs of chronic liver disease: Jaundice, ascites, RUQ pain, confusion (see Cirrhosis).
179
Identify appropriate investigations for hepatocellular carcinoma and interpret the results
Bloods: FBC, LFTs, clotting, alpha fetoprotein, AFP CT/MRI: imaging and staging Biopsy: cytology
180
Define hernias (femoral)
``` A herniation of the contents of the abdomen through the femoral canal Femoral canal: - Anterior border: inguinal ligament - Posterior border: pectineal ligament - Medial border: lacunar ligament - Lateral border: femoral vein ```
181
Explain the aetiology / risk factors of hernias (femoral, inguinal, miscellaneous)
Weakening of abdominal wall allows hernias to protrude through in an increase of intra-abdominal pressure RF: old age, smoking, FHx, gender (female=femoral, male=inguinal), prematurity, pregnancy, weight lifting, constipation, weight gain, chronic cough and previous abdominal surgery/trauma
182
Summarise the epidemiology of hernias (femoral)
Account for 5% of abdominal hernias
183
Recognise the presenting symptoms of hernias (femoral)
Femoral: - Lump in groin, lateral and inferior to pubic tubercle - Appears/swells on coughing, and reduces on relaxation or supination - May be possible to reduce hernia Strangulated: tender, colicky abdominal pain, distension, vomiting
184
Recognise the signs of hernias (femoral) on physical examination
Hernias: reducible, irreducible, obstructed or strangulated Strangulated: lump becomes red and tender
185
Identify appropriate investigations for hernias (femoral, inguinal, miscellaneous) and interpret the results
Diagnosis is largely clinical | Imaging: USS is first line, followed by CT/MRI
186
Generate a management plan for hernias (femoral)
Surgical repair in elective surgery: dissection of the sac, reduction of its contents, completed with sac ligation
187
Identify the possible complications of hernias (femoral) and its management
risk of strangulation at 22%
188
Summarise the prognosis for patients with hernias (femoral, inguinal, miscellaneous)
Good prognosis, mortality for strangulated hernias lies at 2-13%
189
Generate a management plan for hernias (inguinal)
- If small, may only need reassurance | - Elective surgery: dissection of sac, reduction of contents, ligation of sac
190
Identify the possible complications of hernias (inguinal) and its management
recurrence, wound infection, bladder injury, intestinal injury
191
Define hiatus hernias
A herniation of part of the abdominal contents through the oesophageal aperture of the diaphragm Sliding (90%):Gastro-oesophageal junction slides up in to thoracic cavity Rolling (10%): Gastro-oesophageal junction remains in place but a part of the stomach herniates into chest
192
Explain the aetiology / risk factors of hiatus hernias
One or more of three mechanisms: - Widening of diaphragmatic hiatus - Pulling up of the stomach due to oesophageal shortening - Pushing up of the stomach by increased intra-abdominal pressure Risk Factors: increased abdominal pressure (obesity, pregnancy, ascites), age, previous hiatus operation.
193
Recognise the presenting symptoms of hiatus hernias
Sliding: - Can be asymptomatic, retrosternal burning/heartburn, GORD, dysphagia Rolling: - Can be asymptomatic, chest pain, epigastric pain or fullness, nausea May be asymptomatic or may present with heartburn, dysphagia, odynophagia, hoarseness, asthma, shortness of breath, chest pain, anaemia or haematemesis, or some combination of these.
194
Recognise the signs of hiatus hernias on physical examination
See symptoms: tender abdomen
195
Identify appropriate investigations for hiatus hernias and interpret the results
Contrasted upper gastrointestinal series (also known as an upper GI or as a barium oesophagram) is the key investigation. CXR endoscopy
196
Generate a management plan for hiatus hernias
Lifestyle: avoid factors that increase intra-abdominal pressure Pharmacological: PPIs, H2 receptor antagonists Surgical: not asymptomatic sliding hernias, laparoscopic fundoplication Uncomplicated sliding hiatus hernias are treated symptomatically with medical therapy, although some patients may select surgical therapy. Complicated hiatus hernias (those with bleeding, volvulus, or obstruction) have a stronger indication for surgical repair.
197
Identify the possible complications of hiatus hernias and its management
obstruction, bleeding, volvulus with and without strangulation or necrosis, and Barrett's oesophagus Side effects of bloating and dysphagia, recurrence
198
Summarise the prognosis for patients with hiatus hernias
Gain symptomatic relief with medical/surgical treatment, morbidity and mortality higher in >70
199
Define intestinal ischaemia
Impaired blood transfusion to the intestine, resulting in ischaemia of the bowel wall
200
Summarise the epidemiology of intestinal ischaemia
Mainly >50
201
Recognise the signs of intestinal ischaemia on physical examination
tenderness and rebound | cachexia
202
Explain the aetiology / risk factors of intestinal ischaemia
Conditions causing arterial emboli or thrombosis ``` Risk Factors: • old age • history of smoking • hypercoagulable states • atrial fibrillation ```
203
Recognise the presenting symptoms of intestinal ischaemia
sudden severe pain, N&V | Colicky/constant and poorly localised abdominal pain
204
Identify appropriate investigations for intestinal ischaemia and interpret the results
AXR: rule out other causes Angiography: to show blockage ECG: leucocytosis and possible anaemia (if bleeding)
205
Define intestinal obstruction
Mechanical obstruction of the bowel lumen (extrinsic or intrinsic) causing blockage of the intestines
206
Explain the aetiology / risk factors of intestinal obstruction
``` Small Bowel: - Adhesions from prior operations - Malignancy Large Bowel: - Colorectal malignancies Sigmoid/caecal volvulus Paralytic Ileus Postoperative ileus ``` ``` Risk factors • previous abdominal surgery • malrotation • Crohn's disease • hernia ```
207
Summarise the epidemiology of intestinal obstruction
Most are small bowel
208
Recognise the presenting symptoms of intestinal obstruction
``` Diffuse, central colicky pain Vomiting (higher obstruction) [Progression is faster in small bowel] Abdominal distension Progressive constipation and bloating failure to pass flatus or stool ```
209
Recognise the signs of intestinal obstruction on physical examination
Abdominal distension, tympany, high pitched, tinkling bowel sounds Pyrexia – suggests perforation or infarction of bowel
210
Identify appropriate investigations for intestinal obstruction and interpret the results
Bloods: FBC, U&Es, creatinine, group and save Fluid charts Plain AXR & CT
211
Generate a management plan for intestinal obstruction
``` Surgery: - Laparotomy, if no clear diagnosis - Required if signs of peritonitis Non-Surgical treatment: - Drip and suck (bowel decompression) Volvulus: - Can be treated conservatively unless decompression fails/perforation ```
212
Identify the possible complications of intestinal obstruction and its management
Any carcinoma causing obstruction is already advanced | Perforation can cause peritonitis and ischaemia
213
Summarise the prognosis for patients with intestinal obstruction
Small bowel: mortality at 25% with delayed surgery >36 hours; drops to 8% at <36 hours
214
What is functional dyspepsia?
also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the GI tract, including stomach pain or discomfort, nausea, bloating and belching characterised by troublesome early satiety, fullness, or epigastric pain or burning. It can be overlooked as the symptoms overlap with GORD and IBS a chronic disorder of sensation and movement (peristalsis) in the upper GI tract. The cause is unknown; however, several hypotheses could explain this condition. Excessive acid secretion, inflammation of the stomach or duodenum, food allergies, lifestyle and diet influences, psychological factors, medication side effects (from NSAIDs and aspirin), and H.pylori infection have all had their proponents.
215
Define irritable bowel syndrome (IBS)
A functional bowel disorder defined as recurrent episodes of abdominal pain and discomfort for >6 months, associated with >2 of the following: - Altered stool passage - Abdominal bloating - Worsening on eating - Passage of mucous
216
Explain the aetiology / risk factors of functional dyspepsia & irritable bowel syndrome (IBS)
Unknown, psychological factors
217
Summarise the epidemiology of irritable bowel syndrome (IBS)
Common, 10-20% of adults, females 2x more than men
218
Recognise the presenting symptoms of functional dyspepsia & irritable bowel syndrome (IBS)
>6 month history of abdominal pain (colicky in lower abdomen, relieved with defecation/flatus) >3 bowel motions daily or <3 a week Abdominal bloating, change in stool consistency - diarrhoea and constipation Screen for ‘red flag’: weight loss, anaemia, PR bleeding, late onset (>60 years)
219
Recognise the signs of irritable bowel syndrome (IBS) on physical examination
Normally absent signs on examination – can be distended and mildly tender in iliac fossae
220
Identify appropriate investigations for irritable bowel syndrome (IBS) and interpret the results
Diagnosis made by history, investigations used to exclude pathology Bloods: FBC, LFTs, ESR, CRP, TFT Stool examination: MC&S USS: excludes gallstones Hydrogen Breath Test: exclusion of H pylori infection
221
Generate a management plan for irritable bowel syndrome (IBS)
``` Advice: - Dietary modification Medical: - Antispasmodics e.g. buscopan - Prokinetic agents e.g. metoclopramide - Antidiarrhoeals e.g. loperamide - Laxatives e.g. lactulose - Tricyclic antidepressants Psychological Therapies - CBT/relaxation for stress ```
222
Identify the possible complications of irritable bowel syndrome (IBS) and its management
Increase risk of colonic diverticulosis
223
Summarise the prognosis for patients with irritable bowel syndrome (IBS)
Chronic, and relapsing condition – can be exacerbated by stress
224
Define liver abscesses
Abscesses found on the liver (localised infection of liver parenchyma)
225
Summarise the epidemiology of liver abscesses
Caused by bacterial, parasitic or fungal organisms
226
Recognise the presenting symptoms of liver abscesses
Multiple abscesses tend to present more acutely | RUQ pain, tenderness, night sweats, nausea and vomiting, anorexia, dyspnoea
227
Recognise the signs of liver abscesses on physical examination
Hepatomegaly, jaundice, pyrexia
228
Identify appropriate investigations for liver abscesses and interpret the results
Bloods: FBC, ESR, CRP, LFTs USS: shows abscess
229
Explain the aetiology / risk factors of liver cysts
Thought to be congenital
230
Recognise the presenting symptoms of liver cysts
Usually asymptomatic, | Can cause RUQ pain and bloating symptoms
231
Recognise the signs of liver cysts on physical examination
Jaundice, RUQ tenderness
232
Identify appropriate investigations for liver cysts and interpret the results
Bloods: FBC, LFTs Imaging: USS/CT/MRI to show cyst anatomy
233
Summarise the epidemiology of liver cysts
11% incidence
234
Define liver failure
Severe liver dysfunction, causing jaundice, encephalopathy and coagulopathy Hyperacute: <7 days Acute: 1-4 weeks Sub-acute: 4-12 weeks Acute-on-chronic: acute deterioration in chronic liver disease patients
235
Explain the aetiology / risk factors of liver failure
Drugs: paracetamol Viral: Hep A/B/D/E Other: autoimmune liver failure; Budd-Chiari syndrome Pathogenesis: - Jaundice: decreased conjugated bilirubin - Encephalopathy: increased delivery of gut products to systemic circulation - Coagulopathy: decreased clotting factor synthesis ``` Risk Factors • chronic alcohol abuse • poor nutritional status • female sex • age >40 years ```
236
Summarise the epidemiology of liver failure
Paracetamol overdose accounts for 50% of all liver failures
237
Recognise the presenting symptoms of liver failure
Can be asymptomatic Fever, nausea, jaundice abdominal pain, nausea and vomiting
238
Recognise the signs of liver failure on physical examination
Jaundice, encephalopathy, liver asterixis, fetor hepaticus Ascites and splenomegaly, bruising, bleeding Pyrexia
239
Identify appropriate investigations for liver failure and interpret the results
Identify Cause: - Viral serology, paracetamol levels, autoantibodies Bloods: FBC, LFTs, U&Es, glucose, coagulation, ABG, group and save USS/CT: image liver Ascitic fluid: MC&S Doppler: exclude Budd-Chiari syndrome
240
Generate a management plan for liver failure
Resuscitation: ABC Treat Cause: paracetamol overdose Treat/Prevent Complications: - Monitor: vital signs - Manage encephalopathy: lactulose - Antibiotic and antifungal prophylaxis - Hypoglycaemia treatment - Coagulopathy treatment: IV Vitamin K - Gastric mucosa protection: PPI - Avoid: sedatives or liver metabolised drugs - Cerebral Oedema: decrease ICP using mannitol
241
Identify the possible complications of liver failure and its management
Infection, coagulopathy, hypoglycaemia, cerebral oedema, raised ICP
242
Summarise the prognosis for patients with liver failure
Depends on severity
243
Define Mallory-Weiss tear
Mucosal lacerations in the upper gastrointestinal tract; usually at gastro-oesophageal junction or gastric cardia
244
Explain the aetiology / risk factors of a Mallory-Weiss tear
Can be caused by a sudden increase in intragastric pressure | Risk factors: excess alcohol, hyperemesis gravidarum, bulimia, hepatitis, chronic cough
245
Summarise the epidemiology of a Mallory-Weiss tear
Account for 4-8% of upper GI bleeds
246
Recognise the presenting symptoms of a Mallory-Weiss tear
Haematemesis, following a bout of retching or vomiting | Melaena, light-headedness, dizziness, syncope
247
Recognise the signs of a Mallory-Weiss tear on physical examination
Bloods: FBC, clotting screening, U&Es, creatinine, group & save, cardiac enzymes ECG
248
Identify the possible complications of a Mallory-Weiss tear and its management
Vomiting: electrolyte imbalances Bleeding: hypovolaemic shock and death Comorbidities: MI, hepatitis
249
Summarise the prognosis for patients with a Mallory-Weiss tear
Prognosis usually excellent, tears heal rapidly within 48-72 hours; re-bleeding in 8-20% of cases
250
Define NASH
non-alcoholic steatohepatitis
251
Define NASH
non-alcoholic steatohepatitis - An accumulation of fat in the liver, associated with inflammation, not due to excessive alcohol intake
252
Explain the aetiology / risk factors of non-alcoholic steatohepatitis (NASH)
An accumulation of triglycerides and other lipids within hepatocytes Risk Factors: T2DM, polycystuc ovary syndrome, HepB/C HIV, Drugs (amiodarone, tamoxifen), metabolic disorders (Wilson’s)
253
Summarise the epidemiology of non-alcoholic steatohepatitis (NASH)
Most common cause of deranged LFTs
254
Recognise the presenting symptoms of non-alcoholic steatohepatitis (NASH)
Most are asymptomatic – but may report fatigue, malaise or RUQ pain Can present with symptoms of cirrhosis (ascites, oedema and jaundice)
255
Recognise the signs of non-alcoholic steatohepatitis (NASH) on physical examination
Hepatomegaly, splenomegaly, signs of chronic liver disease (spider naevi, ascites, oedema, ABCDE)
256
Identify appropriate investigations for non-alcoholic steatohepatitis (NASH) and interpret the results
Definitive diagnosis can only be made with biopsy Bloods: LFTs, FBC, lipids Imaging: USS/CT Biopsy: only way to diagnose
257
Generate a management plan for non-alcoholic steatohepatitis (NASH)
Advice: • Adequate diet • Weight loss, and control of comorbidities
258
Identify the possible complications of non-alcoholic steatohepatitis (NASH) and its management
Can progress to cirrhosis and liver failure
259
Summarise the prognosis for patients with non-alcoholic steatohepatitis (NASH)
Depends on the stage of disease
260
Define oesophageal cancer
Cancer derived from oesophageal cells
261
Explain the aetiology / risk factors of oesophageal cancer
Majority are SCC and adenocarcinomas Risk Factors: smoking, alcohol, Caucasian, Barrett’s Oesophagus UK: usually adenocarcinoma (as a result of Barrett's oesophagus) Smoking, some Mediterranean/Chinese foods: squamous cell carcinoma
262
Summarise the epidemiology of oesophageal cancer
Common, aggressive tumour
263
Recognise the presenting symptoms of oesophageal cancer
Dysphagia, vomiting, anorexia and weight loss, symptoms of GI blood loss
264
Recognise the signs of oesophageal cancer on physical examination
Lymphadenopathy, weight loss
265
Recognise the signs of oesophageal cancer on physical examination
Lymphadenopathy, weight loss
266
Identify appropriate investigations for oesophageal cancer and interpret the results
Bloods: CEA, Ca19-9, FBC, U&Es, LFTs, glucose, CRP Endoscopy: with biopsy of any lesions CXR: metastases
267
Define pancreatic cancer
Cancer deriving from pancreatic tissue
268
Explain the aetiology / risk factors of pancreatic cancer
11th most common cancer, 5th most common cause of cancer death
269
Summarise the epidemiology of pancreatic cancer
Risk Factors: smoking, diet (high BMI, read meat, low vegetables), diabetes, alcohol
270
Recognise the presenting symptoms of pancreatic cancer
Presents quite late Progressive painless jaundice Late symptoms: abdominal pain, acute pancreatitis, weight loss, haematemesis
271
Recognise the signs of pancreatic cancer on physical examination
Courvoisier’s sign, abdominal tenderness, jaundice
272
Identify appropriate investigations for pancreatic cancer and interpret the results
Bloods: Ca19-9, FBC, LFTs, glucose Imaging: USS, abdominal CT, Endoscopic ultrasound
273
What is Courvoisier’s sign?
gallbladder that’s enlarged due to bile buildup (can usually see or feel it) no pain jaundice not caused by a gallbladder stone, usually a tumour 'in the presence of a palpably enlarged gallbladder which is non-tender and accompanied with mild painless jaundice, the cause is unlikely to be gallstones.'
274
Define acute pancreatitis
autodigestion of the pancreatic tissue
275
Explain the aetiology / risk factors of acute pancreatitis
caused by alcohol abuse and gallstones
276
Explain the aetiology / risk factors of acute pancreatitis
caused by alcohol abuse and gallstones
277
Summarise the epidemiology of acute pancreatitis
common, but usually not severe
278
Recognise the signs of acute pancreatitis on physical examination
cullens and grey-turners mass tender epigastric region
279
Recognise the signs of acute pancreatitis on physical examination
cullens and grey-turners mass tender epigastric region
280
Identify appropriate investigations for acute pancreatitis and interpret the results
bloods: hypocalcaemia (fat necrosis), FBC, CRP,
281
Generate a management plan for acute pancreatitis
- initial fluid resuscitation (+ oxygen. analgesia and anti-emesis if necessary) - Choledocholithiasis without cholangitis - cholecystectomy Cholecystectomy should be delayed in patients with severe/necrotising acute pancreatitis. - gallstone pancreatitis with cholangitis - ERCP within 24 hours - Alcohol-induced pancreatitis: counselling intervention during admission. may need pharmacological treatment for alcohol withdrawal. Vitamin, thiamine and folic acid replacement - with infected pancreatic necrosis: IV ABs, catheter and surgery?
282
Identify the possible complications of acute pancreatitis and its management
Local: pancreatic necrosis, pseudocyst Systemic: MODS, sepsis, renal failure, ARDS Long Term: chronic pancreatitis
283
Summarise the prognosis for patients with acute pancreatitis
20% run severe course with 70% mortality, 80% run milder with 5% mortality
284
Define chronic pancreatitis
Chronic pancreatitis is inflammation due to irreversible changes to the pancreatic structure, like fibrosis, atrophy and calcification. Healthy tissue is replaced by misshaped/stenosed ducts (caused by fibrosis of the ducts), (acinar) atrophy and calcification. This leads to adrenal insufficiency. Chronic inflammatory disease of the pancreas resulting in irreversible parenchymal atrophy and fibrosis, causing, in turn, impaired endocrine and exocrine function and recurrent abdominal pain
285
Explain the aetiology / risk factors of acute pancreatitis
Severe epigastric pain, radiating to the back, relieved by sitting forward Aggravated by movement, exacerbated by eating or drinking alcohol. Weight loss, bloating and steatorrhea Associated with anorexia, nausea and vomiting IMPORTANT: check whether the patient has a history of high alcohol intake or gallstones
286
Recognise the signs of acute pancreatitis on physical examination
Epigastric tenderness Fever Shock (includes tachycardia and tachypnoea) Decreased bowel sounds (due to ileus) In severe pancreatitis: - Cullen's sign (periumbilical bruising) - Grey-Turner sign (flank bruising)
287
Identify appropriate investigations for acute pancreatitis and interpret the results
Bloods: glucose, amylase, lipase, hypocalcaemia, CRP ERCP/MRCP: early changes are duct dilatation and stumping of branches; late changes are duct strictures with alternating dilatation AXR: pancreatic calcification
288
Generate a management plan for acute pancreatitis
General: - Mainly symptomatic treatment and supportive Endoscopic therapy: - Sphincterotomy, stone extraction - Extracorporeal shock-wave lithotripsy used for fragmentation prior to endoscopic removal Surgical: - Indicated if conservative management failed
289
Identify the possible complications of acute pancreatitis and its management
Local: - Pseudocysts, duodenal obstruction, pancreatic ascites Systemic: - Diabetes, steatorrhea, reduced quality of life
290
Summarise the prognosis for patients with acute pancreatitis
Difficult to predict, life expectancy reduced by 10-20 years
291
Define peptic ulcer disease and gastritis
Ulcerations in the GI tract caused by exposure to gastric acid and pepsin.
292
Explain the aetiology / risk factors of peptic ulcer disease and gastritis
Imbalance of damaging pepsin and gastric acid with protective mucosal mechanisms. Common: Very strong association with H pylori (95% of duodenal, 80% of gastric), NSAID use Rare: Zollinger-Ellison syndrome: gastrin secreting pancreatic tumour RF: H.pylori, smoking (increases acid production), age, NSAIDs, burns and head trauma can increase ulcer development Pain- caused by breakdown reaches nerves Bleeding- breakdown reaches blood vessels
293
Summarise the epidemiology of peptic ulcer disease and gastritis
Common, more in men, and annual incidence of 1-4:1000, with duodenal ulcers being more common in younger people Duodenal ulcers are 4x more common than gastric
294
Recognise the presenting symptoms of peptic ulcer disease and gastritis
Epigastric pain, which is relieved by antacids Variable relationship to food: - If worse straight after eating, gastric - If worse hours later/relieved after eating or drinking milk, duodenal May have melaena and haematemesis May have weight loss, but more common in gastric ulcers. Pointing signs: they can point to where the pain is localised H.pylori: epigastric pain that worsens with eating, postprandial belching and epigastric fullness, early satiety, fatty food intolerance, nausea, and occasional vomiting
295
Recognise the signs of peptic ulcer disease and gastritis on physical examination
May be no physical findings | Epigastric tenderness and signs of complications
296
Identify appropriate investigations for peptic ulcer disease and gastritis and interpret the results
Bloods: FBC, amylase, U&Es, clotting, LFT, cross-match, Secretin test (ZE) Endoscopy: (over 55, or alarm symptoms) four quadrant ulcer biopsies to rule out malignancy, no need to biopsy duodenal ulcers Rockall Scoring: for severity after GI bleed H Pylori testing: (If under 55, with no alarm symptoms) - C13-urea breath test - Serology - Stool antigen testing
297
Generate a management plan for peptic ulcer disease and gastritis
Acute: - Resuscitation if perforated/bleeding - IV PPI (omeprazole) Endoscopy: - Haemostasis by electrocoagulation, laser Surgery: - If perforated or bleeding uncontrolled H pylori Eradication: - Tripe Therapy (clarithromycin, amoxicillin + PPI) for 1-2 weeks If non-H pylori: - Treat with PPIs or H2 antagonists, stop NSAID use
298
Identify the possible complications of peptic ulcer disease and gastritis and its management
Haemorrhage, perforation
299
Summarise the prognosis for patients with peptic ulcer disease and gastritis
Lifetime risk is 10%, usually good as can be cured with H pylori eradication
300
Define perineal abscesses
Collection of pus in the anal/rectal region
301
Define perineal fistulae
an abnormal chronically infected tract communicating between the perineal skin and either the anal canal or the rectum
302
Explain the aetiology / risk factors of perineal abscesses and fistulae
Caused by bacterial infection of anal fissure, STIs or blocked anal glands Fistulae develop as a complication of an abscess Fistulae can develop as a complications of Crohn's disease Risk Factors: IBD Diabetes mellitus Malignancy
303
Summarise the epidemiology of perineal abscesses and fistulae
High risk groups include diabetes, immunocompromised, anal sex common
304
Recognise the presenting symptoms of perineal abscesses and fistulae
Painful hardened tissue in perianal area, constant throbbing pain in the perineum Discharge of pus, lump/nodule, tenderness at anus edge, fever, constipation Personal or family history of IBD
305
Recognise the signs of perineal abscesses and fistulae on physical examination
Lump/nodule, tenderness, discharge Small skin lesion near the anus (opening of the fistula) A thickened area over the abscess/fistula may be felt
306
Identify appropriate investigations for perineal abscesses and fistulae and interpret the results
DRE confirms the presence of the fissure | MRI: shows fistular tracts/deep abscesses
307
Generate a management plan for perineal abscesses and fistulae
ABSCESS: Prompt surgical drainage Pain relief Antibiotics usually not necessary FISTULA: Laying Open of Fistula A probe is inserted to explore the fistula. Dye can be inserted into external opening to help find internal opening Low Fistula - Fistulotomy. Care must be taken to prevent damage to the anal sphincter High Fistula - Fistulotomy would cause INCONTINENCE so NOT performed. Seton - a non-absorbable suture that is threaded through the fistula and allows drainage Antibiotics
308
Identify the possible complications of perineal abscesses and fistulae and its management
Systemic infection, fissure, recurrence, scarring Damage to internal anal sphincter Incontinence Persisting pain
309
Summarise the prognosis for patients with perineal abscesses and fistulae
Abscess: Good if treated promptly – 31% can develop a fistula Fistula: High recurrence rate without complete excision
310
Define peritonitis
Inflammation of the peritoneum, can be primary or secondary, localised or generalised
311
Explain the aetiology / risk factors of peritonitis
UGIT: malignancy, trauma, peptic ulcer, iatrogenic LGIT: ischaemic bowel, diverticulitis, hernia, appendicitis Hepatobiliary system: cholecystitis, malignancy, pancreatitis Genitourinary tract: pelvic inflammation, malignancy
312
Recognise the presenting symptoms of peritonitis
Abdominal pain, worsening | Anorexia, nausea and vomiting
313
Recognise the signs of peritonitis on physical examination
Patient appears unwell and distressed; fever; tachycardia Tenderness, guarding and rebound tenderness Patient may lie with knees flexed to avoid abdominal movement
314
Identify appropriate investigations for peritonitis and interpret the results
Bloods: FBC, U&Es, LFTs, MC&S Imaging: AXR, erect CXR, USS, CT, MRI
315
Generate a management plan for peritonitis
Medical: Third-generation cephalosporin, Surgical: Exploratory surgery
316
Identify the possible complications of peritonitis and its management
Sepsis, death
317
Summarise the prognosis for patients with peritonitis
Main prognostic factor is renal dysfunction
318
Define pilonidal sinus
A small hole, or tunnel, that develops at the top of the buttocks An abnormal epithelium-lined tract filled with hair that opens onto the skin surface, most commonly in the natal cleft
319
Explain the aetiology / risk factors of pilonidal sinus
Abnormal hair growth, that grows into the skin rather than out of it (caused by shed or sheared hairs penetrating the skin) inciting and inflammatory reaction and sinus development ``` Risk Factors sedentary life-style, obesity, friction Hirsutism Spending a long time sitting down Occupational (e.g. hairdressers may develop interdigital pilonidal sinus) ```
320
Summarise the epidemiology of pilonidal sinus
COMMON | Affects 0.7% of young adults
321
Recognise the presenting symptoms of pilonidal sinus
Boil-like lump, pain, swelling, redness, pus discharge Painful natal cleft Often recurrent
322
Recognise the signs of pilonidal sinus on physical examination
Midline openings or pits between the buttocks Hairs may protrude from the swelling If infection or abscess, the swelling will become tender It may be fluctuant and discharge pus or blood-stained fluid on compression Fever, erythema, swelling, lump
323
Identify appropriate investigations for pilonidal sinus and interpret the results
No real investigation, diagnosis made on examination
324
Generate a management plan for pilonidal sinus
Advice: • Should be kept dry and clean, and area kept hair-free Medical: • Antibiotics: If there is pus or an abscess Surgical: • Incision and drainage, under general anaesthetic (acute) • Excision: removing the skin around the sinus (chronic)
325
Identify the possible complications of pilonidal sinus and its management
Pain Infection Abscess Recurrence
326
Summarise the prognosis for patients with pilonidal sinus
Good, simply needs to be treated
327
Define portal hypertension
Abnormally high pressure in the hepatic portal vein; an hepatic venous gradient pressure of >12mmHg
328
Explain the aetiology / risk factors of portal hypertension
Pre-Hepatic: - Congenital atresia or stenosis - Portal vein thrombosis; splenic vein thrombosis - Extrinsic compression e.g. tumours Hepatic: - Cirrhosis; chronic hepatitis - Schistosomiasis; granulomata Post-hepatic: - Budd-Chiari syndrome (hepatic vein obstruction) - Constrictive pericarditis; right heart failure Other: - Increased hepatic blood flow (splenomegaly) - Idiopathic Left-sided portal hypertension - Rare, confined to left side of portal system; presents as gastric varices bleeding
329
Summarise the epidemiology of portal hypertension
Common in liver disease
330
Recognise the presenting symptoms of portal hypertension
For Liver disease: - History of jaundice, alcohol consumption, blood transfusion (hep B or C susceptibility), family history For complications: - Malaena, lethargy, abdominal distension, abdominal pain and fever
331
Recognise the signs of portal hypertension on physical examination
Dilated veins in anterior abdominal wall and caput medusa Venous hum, loudest in inspiration Splenomegaly; ascites ``` Signs of Portal Hypertension - Caput medusae - Splenomegaly - Ascites Signs of Liver Failure - Jaundice - Spider naevi - Palmar erythema - Confusion - Asterixis - Fetor hepaticus (breathe of the dead) - Enlarged or small liver - Gynaecomastia - Testicular atrophy ```
332
Identify appropriate investigations for portal hypertension and interpret the results
``` Bloods: LFTs, U&Es, FBC, glucose, clotting Portal Hypertension Measurement: HVPG Scans: USS, Doppler, CT/MRI Endoscopy: for oesophageal varices Biopsy: if indicated ```
333
Generate a management plan for portal hypertension
Difficult to treat, except by treating cause Drug: - Beta Blockers (carvedilol) reduces portal pressure - Nitrates reduces portal pressure - Vasoactive drugs (terlipressin and octreotide) to assist in acute bleeding Endoscopy: - To detect, monitor and treat varices Transjugular intrahepatic portosystemic shunt (TIPS) - Using a shunt to connect portal and hepatic veins, decompressing the portal system - Ascites, oesophageal varices and gastric varices Surgery: - Surgical portosystemic shunts
334
Identify the possible complications of portal hypertension and its management
Bleeding, ascites, pulmonary problems, liver failure, hepatic encephalopathy, cirrhotic cardiomyopathy
335
Summarise the prognosis for patients with portal hypertension
Depends on underlying disease, Child-Pugh score determines prognosis
336
Define primary biliary cirrhosis
Chronic inflammatory liver disease of the bile system, leading to cholestasis and cirrhosis
337
Explain the aetiology / risk factors of primary biliary cirrhosis
Unknown, autoimmune aetiology is likely
338
Recognise the presenting symptoms of primary biliary cirrhosis
Can be an incidental finding (from detecting high ALP) Insidious onset fatigue, weight loss and pruritus Discomfort in the RUQ (rarely) Can present with a complication, or associated conditions
339
Recognise the signs of primary biliary cirrhosis on physical examination
Early: no signs Late: jaundice, skin pigmentation, excoriation marks, xanthomas, xanthomata, hepatomegaly, ascites - Liver disease signs (palmar erythema, spider naevi, clubbing)
340
Identify appropriate investigations for primary biliary cirrhosis and interpret the results
Bloods: LFT (increased AlkPhos, GGT and bilirubin) Anti-mitochondrial antibodies are hallmark feature USS: exclude extrahepatic biliary obstruction Liver Biopsy: chronic inflammatory cells and granulomas around intrahepatic bile ducts
341
Define primary sclerosing cholangitis
Chronic cholestatic liver disease characterised by progressive inflammatory fibrosis and obliteration of intrahepatic and extrahepatic bile ducts
342
Explain the aetiology / risk factors of primary sclerosing cholangitis
Unknown, possible genetic predisposition with toxic/infective triggers
343
Summarise the epidemiology of primary sclerosing cholangitis
more common in males (60% affects all ages associated with IBD
344
Recognise the presenting symptoms of primary sclerosing cholangitis
Can be asymptomatic and diagnosed after an incidental finding of increased AlkPhos Intermittent jaundice, pruritus, RUQ pain, weight loss and fatigue Episodic fever, rigors, is less common History of UC and symptoms of complications
345
Recognise the signs of primary sclerosing cholangitis on physical examination
May have no signs | Evidence of: jaundice, hepatosplenomegaly, spider naevi, palmar erythema and ascites
346
Identify appropriate investigations for primary sclerosing cholangitis and interpret the results
Bloods: LFTs (increased AlkPhos, GGT, bilirubin and transaminases, decreased albumin) Serology: immunoglobulin levels (increased IgG (children) and IgM (Adults)) ERCP: structuring and interspersed dilation of bile ducts MRCP: non-invasive imaging Liver Biopsy: confirm diagnosis, and allows staging
347
Summarise the epidemiology of primary biliary cirrhosis
more common in females | onset mostly at middle age
348
Define rectal prolapse
The protrusion of either the rectal mucosa or the entire wall of the rectum Partial: only mucosa involvement Complete: all layers of the rectal wall
349
Explain the aetiology / risk factors of rectal prolapse
Risk Factors: increased intra-abdominal pressure, previous surgery, pelvic floor dysfunction
350
Summarise the epidemiology of rectal prolapse
Uncommon
351
Recognise the presenting symptoms of rectal prolapse
Due to a lax sphincter, prolonger straining, and related to chronic neurological and psychological disorders. Risk Factors: increased intra-abdominal pressure, previous surgery, pelvic floor dysfunction
352
Recognise the signs of rectal prolapse on physical examination
Protruding mass at anus, possible tenderness
353
Identify appropriate investigations for rectal prolapse and interpret the results
Barium enema/colonoscopy: evaluate entire colon prior to surgery Other investigations to assess underlying conditions (e.g. stool microscopy)
354
Define ulcerative colitis
Chronic relapsing and remitting inflammatory condition affecting the large bowel
355
Explain the aetiology / risk factors of ulcerative colitis
Unknown, suggested genetic susceptibility, family history component inappropriate immune response in a genetically susceptible individual
356
Summarise the epidemiology of ulcerative colitis
1:1500, common in Ashkenazi Jews and Caucasians 15-30s onset smoking increases risk NSAIDs may exacerbate
357
Recognise the presenting symptoms of ulcerative colitis
Bloody diarrhoea, or mucous, tenesmus and urgency Weight loss, fever, abdominal pain before passing stool
358
Recognise the signs of ulcerative colitis on physical examination
Iron-deficiency anaemia, dehydration, clubbing, abdominal tenderness, tachycardia DRE: blood, mucous, tenderness
359
Identify appropriate investigations for ulcerative colitis and interpret the results
Bloods: FBC, ESR, CRP, LFTs (p-anca positive) Stool: culture (exclude infectious colitis) AXR: exclude toxic megacolon Flexible sigmoidoscopy: determines severity, histological confirmation Barium enema: mucosal ulceration with granular appearance
360
Generate a management plan for ulcerative colitis
Observe activity markers: - Haemoglobin, albumin, ESR, CRP and diarrhoea frequency Acute Exacerbations: - IV rehydration, IV corticosteroids, antibiotics - Bowel rest, parenteral feeding, DVT prophylaxis - Mild disease: topical/oral 5-ASA derivatives e.g. mesalazine/sulphasalazine - Moderate/Severe disease: oral steroids and oral 5-ASA (sulphasalazine) and immunosuppression (azathioprine, cyclosporine) Advice: - Patient education and support - Treatment of complications Surgical: - Indicated if failure of medical treatment - Proctocolectomy with ileostomy or an ileo-anal pouch formation
361
Identify the possible complications of ulcerative colitis and its management
GI: haemorrhage, toxic megacolon, perforation, colonic carcinoma Extra-GI: uveitis, arthropathy, renal calculi
362
Summarise the prognosis for patients with ulcerative colitis
Relapsing and remitting condition: normal life expectancy Poor Prognosis: ABCDE; albumin <30, blood PR, CRP raised, dilated loops of bowel, eight or more bowel movements per day, fever
363
Define viral hepatitis
Inflammation of the liver, due to a viral cause
364
Explain the aetiology / risk factors of viral hepatitis
Causes are hepatitis viruses, HAV, HBV, HCV, HDV, HEV, EBV, CMV, (malaria, Q fever, syphilis, yellow fever) Hep A spread by faecal-oral route or shellfish Hep B spread by blood products, IV drug abused and physical or sexual contact Hep C spread by blood: transfusion, IV drug abuse, sexual contact. RF: male, older, high viral use, alcohol use, HIV, HBV
365
Summarise the epidemiology of viral hepatitis
Incidence is declining Hep A endemic in africa and S.America. Hep B endemic in Far East, Africa and mediterranean
366
Recognise the presenting symptoms of viral hepatitis
Acute Infection: • Nausea and vomiting; myalgia, fatigue, malaise • RUQ pain; change in smell or taste • Photophobia and headache Chronic infection: • May be asymptomatic Can lead to chronic hepatitis, cirrhosis and HCC
367
Recognise the signs of viral hepatitis on physical examination
RUQ tenderness, fever, hepatomegaly | Later: Jaundice, hepatosplenomegaly, arthralgia, urticaria
368
Identify appropriate investigations for viral hepatitis and interpret the results
Bloods: FBC, U&Es, LFTs, clotting factors, serology Imaging: USS/CT/MRI to assess cirrhosis
369
Generate a management plan for viral hepatitis
``` HAV: • Mainly symptomatic; avoid alcohol HBV: • Advice: avoid unprotected sex, education • Treat acute infection: mainly symptomatic HCV: • Largely symptomatic; avoid excess alcohol • Drug therapy: peginterferon HDV: • Pegylated interferon alpha • Liver transplant HEV: • Mainly supportive, as HAV ```
370
Identify the possible complications of viral hepatitis and its management
Cirrhosis, liver failure, Guillian-Barre syndrome, hepatitis, HCC
371
Summarise the prognosis for patients with viral hepatitis
Poor without treatment, especially fatal in the elderly
372
What type of bacteria is H.pylori?
helical-shaped gram-negative
373
Define volvulus
Rotation of a loop of small bowel around the axis of its mesentery that results in bowel obstruction and potential ischaemia. The areas usually affected: - Sigmoid colon - 65% - Caecum - 30% - VOLVULUS NEONATORUM - occurs in neonates and typically affects the midgut Long, and twisted colon, usually in the sigmoid colon
374
Explain the aetiology / risk factors of volvulus
Full bowel twists on its mesenteric pedicle to create a closed-loop obstruction Risk Factors: elderly, chronic constipation, megacolon ``` Risk Factors Adults - Long sigmoid colon - Long mesentery - Mobile caecum - Chronic constipation - Adhesions - Chagas disease - Parasitic infections Neonatal - Malrotation ```
375
Summarise the epidemiology of volvulus
Leading cause of obstruction in lesser developed countries
376
Recognise the presenting symptoms of volvulus
Sudden onset severe colicky pain, associated with a distended abdomen, complete/absolute constipation Vomiting There may be a history of transient attacks in which spontaneous reduction of the volvulus has occurred Neonatal volvulus presents around 3 months
377
Recognise the signs of volvulus on physical examination
Distended abdomen, non-tender, palpable mass may be present ``` Signs of bowel obstruction with abdominal distension and tenderness Absent or tinkling bowel sounds Fever Tachycardia Signs of dehydration ```
378
Identify appropriate investigations for volvulus and interpret the results
AXR: shows signs of volvulus (coffee bean or embryo) | May need barium enema - show obstruction
379
Define Wilson's disease
An autosomal recessive disorder characterised by a reduced biliary excretion of copper, and accumulation in the liver and brain, especially in the basal ganglia
380
Explain the aetiology / risk factors of Wilson's disease
Gene responsible is on chromosome 13 Mutation in a gene on chromosome 13 that codes for copper transporting ATPase (ATP7B) in hepatocytes This interferes with the transport of copper into the intracellular compartments for incorporation into caeruloplasmin (copper containing complex) Caeruloplasmin is normally secreted into plasma or excreted in bile Excess copper damages the hepatocyte mitochondria, leading to cell death and release of free copper into the plasma This free copper then gets deposited in tissues and impairs tissue function
381
Summarise the epidemiology of Wilson's disease
Liver disease may present in children | Neurological disease usually presents in young adults
382
Recognise the presenting symptoms of Wilson's disease
Liver: (may present with hepatitis, liver failure or cirrhosis;) jaundice, easy bruising, variceal bleeding, encephalopathy Neurological: dyskinesia, rigidity, tremor, dystonia, dysarthria, dysphagia, drooling, dementia, ataxia Psychiatric: conduct disorders, personality changes and psychosis
383
Recognise the signs of Wilson's disease on physical examination
Liver: hepatosplenomegaly, jaundice, ascites/oedema, gynaecomastia Neurological: (same as symptoms) dyskinesia, rigidity, tremor, dystonia, dysarthria, dysphagia, drooling, dementia, ataxia Eyes: green/brown Kayser-Fleischer rings in the corneal limbus, sunflower cataract
384
Identify appropriate investigations for Wilson's disease and interpret the results
Bloods: LFTs, copper 24-hour urinary copper levels: increased Liver biopsy: increased copper content Genetic analysis: no simple genetic test to diagnose